Irritable Bowel Syndrome Research Today is a free monthly online journal that collates and summarizes the latest research about Irritable Bowel Syndrome, including details on treatment, symptoms, digestion, nutrition, diet, drugs.

Volume 8 (2011), Issue 5 (May)

1. HLA-DQ genotype is associated with accelerated small bowel transit in patients with diarrhea-predominant irritable bowel syndrome.
   Eur J Gastroenterol Hepatol, 23(6): 481-7. [Abstract] [Full-text]
2. Physical activity improves symptoms in irritable bowel syndrome: a randomized controlled trial.
   Am J Gastroenterol, 106(5): 915-22. [Abstract] [Full-text]
3. Treatment of irritable bowel syndrome.
   J Clin Pharm Ther, 36(3): 275-82. [Abstract] [Full-text]
4. Effects of probiotic fermented milk on symptoms and intestinal flora in patients with irritable bowel syndrome: a randomized, placebo-controlled trial.
   Scand J Gastroenterol, 46(6): 663-72. [Abstract] [Full-text]
5. Oral baclofen reduces visceral pain-related pseudo-affective responses to colorectal distension in rats: relation between plasma exposure and efficacy.
   Scand J Gastroenterol, 46(6): 652-62. [Abstract] [Full-text]
6. All-cause health care charges among managed care patients with constipation and comorbid irritable bowel syndrome.
   Postgrad Med, 123(3): 122-32. [Abstract] [Full-text]
7. White matter abnormalities in irritable bowel syndrome and relation to individual factors.
   Brain Res, 1392: 121-31. [Abstract] [Full-text]
8. Efficacy and safety of oral lubiprostone in constipated patients with or without irritable bowel syndrome: a randomized, placebo-controlled and dose-finding study.
   Neurogastroenterol Motil, 23(6): 544-e205. [Abstract] [Full-text]
9. Factors associated with co-morbid irritable bowel syndrome and chronic fatigue-like symptoms in functional dyspepsia.
   Neurogastroenterol Motil, 23(6): 524-e202. [Abstract] [Full-text]
10. Randomised clinical trial: the clinical effects of a novel neurokinin receptor antagonist, DNK333, in women with diarrhoea-predominant irritable bowel syndrome.
    Aliment Pharmacol Ther, 33(12): 1311-21. [Abstract] [Full-text]
11. Microbial community and metabolomic comparison of irritable bowel syndrome faeces.
    J Med Microbiol, 60: 817-27. [Abstract] [Full-text]
12. Lubiprostone for the treatment of adults with constipation and irritable bowel syndrome.
    Dig Dis Sci, 56(6): 1619-25. [Abstract] [Full-text]
13. Operant learning of perceptual sensitization and habituation is impaired in fibromyalgia patients with and without irritable bowel syndrome.
    Pain, 152(6): 1408-17. [Abstract] [Full-text]
14. When to reconsider the diagnosis of irritable bowel syndrome.
    Gastroenterol Clin North Am, 40(2): 291-307, vii. [Abstract] [Full-text]
15. Treatment of irritable bowel syndrome in women.
    Gastroenterol Clin North Am, 40(2): 265-90, vii. [Abstract] [Full-text]
16. A cognitive-behavioral treatment for irritable bowel syndrome using interoceptive exposure to visceral sensations.
    Behav Res Ther, 49(6): 413-21. [Abstract] [Full-text]
17. Analgesic effect of Coptis chinensis rhizomes (Coptidis Rhizoma) extract on rat model of irritable bowel syndrome.
    J Ethnopharmacol, 135(3): 754-61. [Abstract] [Full-text]
18. Existing and emerging therapies for irritable bowel syndrome.
    Expert Opin Emerg Drugs, 16(2): 389-402. [Abstract] [Full-text]
19. Questioning the bacterial overgrowth hypothesis of irritable bowel syndrome: an epidemiologic and evolutionary perspective.
    Clin Gastroenterol Hepatol, 9(6): 461-9; quiz e59. [Abstract] [Full-text]
20. Magnetic resonance imaging of rectal volume in patients with irritable bowel syndrome.
    Dig Liver Dis, 43(7): 529-34. [Abstract] [Full-text]

© 2004-2012 Irritable Bowel Syndrome Research Today. All Rights Reserved.